ACLS on Nasdaq
Axcelis Technologies
Logo: Axcelis Technologies, Public domain, via Wikimedia Commons4
American semiconductor equipment manufacturer
Axcelis Technologies, Inc. is an American company engaging in the design, manufacture, and servicing of capital equipment for the semiconductor manufacturing industry worldwide.3 From Wikipedia, CC BY-SA 4.0
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with ACM Research, Inc., Cricut or Veeco, or pick any stock.
- TickerACLS on Nasdaq1
- IndustrySpecial Industry Machinery, NEC1
- HeadquartersBeverly1
- Websitewww.axcelis.com
- Legal formDelaware corporation1
- Incorporated inDE5
- Business address108 Cherry Hill Drive, Beverly, Ma 019155
- Filer categoryLarge accelerated filer5
See how the biggest companies compare on our leaderboards
Axcelis Technologies, Inc. is an American company engaging in the design, manufacture, and servicing of capital equipment for the semiconductor manufacturing industry worldwide. It produces ion implantation systems, including high and medium current implanters, and high energy implanters, and curing systems used in the fabrication of semiconductor chips. The company was incorporated in 1995 and is headquartered in Beverly, Massachusetts, United States.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Ion implantation systems and services brought in 49% of the revenue Axcelis Technologies broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| Ion implantation systems and services | $1.1B | $1.0B | $824.1M |
| Systems | $883.6M | $782.6M | $571.0M |
| Aftermarket | $247.0M | $235.3M | $268.0M |
| Other systems and services | $19.3M | $16.8M | $14.9M |
Regions
Asia Pacific brought in 46% of the revenue Axcelis Technologies broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| Asia Pacific | $811.3M | $781.0M | $610.2M |
| United States | $749.3M | $632.0M | $482.6M |
| North America | $174.8M | $144.1M | $137.1M |
| Europe | $144.5M | $92.8M | $91.8M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue55¢$462.2M
- Research and development13¢$109.0M
- Other costs15¢$129.6M
- Income tax2¢$18.0M
- Profit14¢$120.2M
Out of $839.0M in revenue.7
Where each dollar of operating cash went, fiscal 2025
- Capital spending9¢$11.3M
- Share buybacks91¢$121.1M
Out of $118.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.7
Financial statements
Every line of the income statement in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total revenue | $839.0M | $1.0B | $1.1B |
| Total cost of revenue | $462.2M | $563.2M | $639.3M |
| Gross profit | $376.8M | $454.7M | $491.3M |
| Research and development | $109.0M | $105.5M | $96.9M |
| Sales and marketing | $65.4M | $68.0M | $62.8M |
| General and administrative | $83.2M | $70.3M | $65.8M |
| Total operating expenses | $257.5M | $243.9M | $225.5M |
| Income from operations | $119.3M | $210.8M | $265.8M |
| Interest income | $21.5M | $24.4M | $18.2M |
| Interest expense | -$5.4M | -$5.5M | -$5.3M |
| Other, net | $2.8M | $539.0K | -$48.0K |
| Total other income | $18.9M | $19.5M | $12.8M |
| Income before income taxes | $138.2M | $230.3M | $278.6M |
| Income tax provision | $18.0M | $29.3M | $32.3M |
| Net income | $120.2M | $201.0M | $246.3M |
| Basic | $3.81 | $6.17 | $7.52 |
| Diluted | $3.80 | $6.15 | $7.43 |
| Basic weighted average shares of common stock | 31.6M shares | 32.6M shares | 32.8M shares |
| Diluted weighted average shares of common stock | 31.7M shares | 32.7M shares | 33.2M shares |
Every line of the balance sheet in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $145.5M | $123.5M | |
| Short-term investments | $228.8M | $447.8M | |
| Accounts receivable, net | $168.5M | $203.1M | |
| Inventories, net | $329.0M | $282.2M | |
| Prepaid income taxes | $4.7M | $6.4M | |
| Prepaid expenses and other current assets | $66.8M | $60.5M | |
| Total current assets | $943.2M | $1.1B | |
| Property, plant and equipment, net | $56.1M | $53.8M | |
| Operating lease assets | $28.9M | $29.6M | |
| Finance lease assets, net | $14.2M | $15.3M | |
| Long-term restricted cash | $10.6M | $7.6M | |
| Deferred income taxes | $79.9M | $68.3M | |
| Long-term investments | $182.4M | ||
| Other assets | $46.0M | $50.6M | |
| Total assets | $1.4B | $1.3B | |
| Accounts payable | $42.3M | $46.9M | |
| Accrued compensation | $34.2M | $25.5M | |
| Warranty | $9.5M | $13.0M | $14.1M |
| Income taxes | $11.4M | ||
| Deferred revenue | $65.5M | $94.7M | |
| Current portion of finance lease obligation | $1.6M | $1.3M | |
| Other current liabilities | $33.1M | $26.0M | |
| Total current liabilities | $197.7M | $207.5M | |
| Long-term finance lease obligation | $40.8M | $42.3M | |
| Long-term deferred revenue | $43.4M | $43.5M | |
| Other long-term liabilities | $44.8M | $42.6M | |
| Total liabilities | $326.7M | $336.0M | |
| Common stock, $0.001 par value, 75,000 shares authorized; 30,717 shares issued and outstanding at December 31, 2025; 32,365 shares issued and outstanding at December 31, 2024 | $31.0K | $32.0K | |
| Additional paid-in capital | $533.3M | $548.7M | |
| Retained earnings | $503.5M | $470.3M | |
| Accumulated other comprehensive loss | -$2.2M | -$6.2M | |
| Total stockholders' equity | $1.0B | $1.0B | $864.9M |
| Total liabilities and stockholders' equity | $1.4B | $1.3B | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, shares authorized | 75.0M shares | 75.0M shares | |
| Common stock, shares issued | 30.7M shares | 32.4M shares | |
| Common stock, shares outstanding | 30.7M shares | 32.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.7
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $120.2M | $201.0M | $246.3M |
| Depreciation and amortization | $17.6M | $15.8M | $13.1M |
| Deferred income taxes | -$10.7M | -$15.6M | -$20.0M |
| Stock-based compensation expense | $20.8M | $21.0M | $18.3M |
| Provision for doubtful accounts | $3.0M | $1.1M | |
| Provision for excess and obsolete inventory | $3.9M | $6.0M | $5.2M |
| Accretion of discounts and premiums on short-term and long-term investments | -$4.2M | -$12.4M | -$12.1M |
| Unrealized currency gain on foreign denominated transactions | $1.9M | $7.8M | $2.3M |
| Mark-to-market adjustment on forward exchange contracts | -$435.0K | -$267.0K | |
| Accounts receivable | $37.4M | $6.9M | -$50.8M |
| Inventories | -$42.2M | $5.9M | -$70.0M |
| Prepaid expenses and other current assets | -$5.2M | -$11.7M | -$16.0M |
| Accounts payable and other current liabilities | $6.2M | -$413.0K | -$8.1M |
| Deferred revenue | -$29.7M | -$71.1M | $56.2M |
| Income taxes | $13.1M | -$9.0M | $3.8M |
| Other assets and liabilities | -$10.5M | -$6.0M | -$12.3M |
| Net cash provided by operating activities | $118.3M | $140.8M | $156.9M |
| Expenditures for property, plant and equipment and capitalized software | -$11.3M | -$12.2M | -$20.7M |
| Purchases of short-term and long-term investments | -$646.0M | -$539.1M | -$388.8M |
| Maturities and sales of short-term investments | $687.2M | $442.6M | $308.6M |
| Net cash provided by (used in) investing activities | $29.9M | -$108.7M | -$100.9M |
| Net settlement on restricted stock grants | -$4.5M | -$11.6M | -$16.6M |
| Repurchase of common stock | -$121.1M | -$60.5M | -$52.5M |
| Proceeds from Employee Stock Purchase Plan purchases | $2.5M | $2.4M | $2.1M |
| Principal payments on finance lease obligation | -$1.4M | -$1.5M | -$1.2M |
| Proceeds from exercise of stock options | $25.0K | ||
| Net cash used in financing activities | -$124.5M | -$71.2M | -$68.3M |
| Effect of exchange rate changes on cash and cash equivalents | $1.3M | -$3.8M | -$139.0K |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $25.0M | -$42.9M | -$12.4M |
| Interest | $4.6M | $4.7M | $4.9M |
Timeline
- 1995Founded Founded1
Recent filings
- Sep 16, 20264
- Sep 16, 20264
- Aug 6, 20268-K
- Aug 6, 2026SCHEDULE 13G/A
- Aug 6, 202610-Q
- Jul 17, 20264
- Jul 14, 2026SCHEDULE 13G/A
- Jun 17, 20264
- Jun 16, 20264
- Jun 4, 20264
- Jun 3, 2026144
- Jun 3, 20264
- Jun 2, 2026144
- May 28, 20264
- May 27, 2026SD
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websitewww.axcelis.com1
- WikipediaAxcelis Technologies
- WikidataQ4830196
- SEC EDGARCIK 1113232
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1WikidataAxcelis Technologies on Wikidata
- 2
- 3WikipediaAxcelis Technologies on Wikipedia
- 4Wikimedia CommonsAxcelis Technologies logo by Axcelis Technologies, Public domain
- 5
- 6Wikimedia CommonsAxcelis Technologies photo by John Phelan, CC BY-SA 4.0
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14